Dolutegravir plus rilpivirine: benefits beyond viral suppression von Jesús Troya, MD, PhD, Carlos Dueñas, MD, Idoia Irazola, MD, Ignacio de los Santos, MD, PhD, Sara de la Fuente, MD, PhD, Desiré Gil, MD, PhD, Cristina Hernández, MD, María José Galindo, MD, PhD, Julia Gómez, MD, Elisabeth Delgado, MD, Estela Moreno-García, MD, Guillermo Posada, MD, PhD, Teresa Aldámiz, MD, PhD, Jose Antonio Iribarren, MD, José Manuel Guerra, MD, PhD, Miguel Ángel Morán, MD, Carlos Galera, MD, PhD, Javier Fuente, MD, Ana Peláez, MD, PhD, Miguel Cervero, MD, PhD, María Garcinuño, MD, Marta Montero, MD, Francisco Ceballos, PhD, Luis Buzón, MD, PhD, on behalf of the DORIPEX Study Group∗∗

Volltext

Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study von Rodríguez-Pardo, D., Pigrau, C., Lora-Tamayo, J., Soriano, A., del Toro, M.D., Cobo, J., Palomino, J., Euba, G., Riera, M., Sánchez-Somolinos, M., Benito, N., Fernández-Sampedro, M., Sorli, L., Guio, L., Iribarren, J.A., Baraia-Etxaburu, J.M., Ramos, A., Bahamonde, A., Flores-Sánchez, X., Corona, P.S., Ariza, J.

Volltext

Decrease in Serial Prevalence of Coinfection with Hepatitis C Virus among HIV-Infected Patients in Spain, 1997–2006 von Cachafeiro, Santiago Pérez, Del Amo, Julia, Iribarren, Jose A., Salavert Lleti, Miguel, Gutiérrez, Félix, Moreno, Ana, Labarga, Pablo, Pineda, Juan A., Vidal, Francesc, Berenguer, Juan, Moreno, Santiago

Volltext

Hiv-infected progressors and long-term non-progressors differ in their capacity to respond to an A-class CpG oligodeoxynucleotide von SAEZ, Raquel, ECHANIZ, Pilar, DE JUAN, Maria Dolores, IRIBARREN, José Antonio, CUADRADO, Emilio

Volltext